European Union Drugs Agency. (2024) Harm reduction – the current situation in Europe (European Drug Report 2024).
External website: https://www.euda.europa.eu/publications/european-d...
Harm reduction encompasses interventions, programmes and policies that seek to reduce the health, social and economic harms of drug use to individuals, communities and societies. On this page, you can find the latest analysis of harm reduction interventions in Europe, including key data on opioid agonist treatment, naloxone programmes, drug consumption rooms and more.
This page is part of the European Drug Report 2024, the annual overview of the drug situation in Europe.
B Substances > Opioids (opiates) > Opioid product > Naloxone
B Substances > New (novel) psychoactive substances > Benzodiazepines
B Substances > New (novel) psychoactive substances > Synthetic opioids
B Substances > New (novel) psychoactive substances > Other novel substances > Xylazine, detomidine, medetomidine
G Health and disease > Substance use disorder (addiction) > Drug use disorder > Drug intoxication > Poisoning (overdose)
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
J Health care, prevention, harm reduction and treatment > Harm reduction > Substance use harm reduction
J Health care, prevention, harm reduction and treatment > Identification and screening > Identification and screening for substance use > Drug checking / testing service
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control > Needle syringe distribution and exchange
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education
L Social psychology and related concepts > Physical context, location or place > Safe spaces (injecting facilities / centre / consumption rooms)
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use > Harm reduction policy
N Communication, information and education > Information use and impact
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > Europe
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page